The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase.
about
Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseasesBridge between neuroimmunity and traumatic brain injuryReactive carbonyl species and their roles in sarcoplasmic reticulum Ca2+ cycling defect in the diabetic heartAntioxidant-based therapies for angiotensin II-associated cardiovascular diseasesNanocarriers for vascular delivery of antioxidantsConjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivoNeuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration.Agile delivery of protein therapeutics to CNSPECAM-targeted delivery of SOD inhibits endothelial inflammatory responseSOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature.Angiotensin II and angiotensin-1-7 redox signaling in the central nervous system.Anti-inflammatory effect of targeted delivery of SOD to endothelium: mechanism, synergism with NO donors and protective effects in vitro and in vivo.Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells.Statin therapy lowers muscle sympathetic nerve activity and oxidative stress in patients with heart failureSuperoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation.Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injuryMitochondrial-localized NADPH oxidase 4 is a source of superoxide in angiotensin II-stimulated neurons.Over-expressed copper/zinc superoxide dismutase localizes to mitochondria in neurons inhibiting the angiotensin II-mediated increase in mitochondrial superoxide.Effects of exercise training on SFO-mediated sympathoexcitation during chronic heart failure.Tailoring nanocarriers for intracellular protein delivery.Targeted interception of signaling reactive oxygen species in the vascular endotheliumNanocarriers for vascular delivery of anti-inflammatory agentsMolecular characterization of reactive oxygen species in systemic and pulmonary hypertension.Design and processing of nanogels as delivery systems for peptides and proteins.Targeted endothelial nanomedicine for common acute pathological conditions.Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavengingNeuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly(2-oxazoline)s nanoformulation.Nanoformulated copper/zinc superoxide dismutase reduces adipose inflammation in obesity.An intracellular protein delivery platform based on glutathione-responsive protein nanocapsules.Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype.
P2860
Q21133553-900ACD15-81B6-4CCB-81AA-FDF4D969AEA0Q26827612-42A08178-3C3C-4DFA-AD3A-9599DEE298E4Q26849625-011654AF-A6C1-47F3-965C-97F810CFD8ACQ27016563-6160F92F-7C31-489D-A544-3CC060A6B2A2Q27027067-625F2DF4-4169-43ED-AF87-26B535719F82Q30535357-CD62EF16-6130-40F1-84E0-4BF49F795CC1Q33978310-20F9057C-B449-483C-B21F-C8D9BD68710AQ34079647-A119D1CD-78D7-42D5-BE6C-3D03DEA61FB1Q34421779-961079DD-8DFB-4CC0-91F3-C213B02E1A94Q34481558-A83EF239-58FE-4358-8EEE-021DF4603B20Q34785701-04B2D921-6820-472B-91C5-E7050D8CBDA4Q35023022-2DE26C1D-EADB-49DF-BC5F-5C1A42BF52B5Q35194750-A1187F62-D114-4871-8A55-4C10E6800E6EQ36176118-20D6094C-8B06-42AF-AB58-33D0513AD3F5Q36369061-C3D2C5DB-D4E3-4BD2-8241-0B6E1E5BF3B3Q36684451-E0A48336-3B2F-4B74-961D-D7BAC7457227Q37054954-B671468D-287F-403C-8139-1EC642A5BD44Q37392065-54790D1F-F633-482D-959C-3D3A633B0848Q37575972-342E47B5-F17B-45B3-B4E9-FC7233C89B08Q37874945-89DC7D89-B835-4228-9E04-4E5E5CB8EFD5Q38029695-97772C7F-21AB-4B49-885D-4AB48F498E24Q38176037-64C55715-3F24-426F-A5FD-FED2CCCBEED2Q38189533-18C18CBE-EAF8-4536-8813-9979A22B6300Q38236697-DCCFD7D4-4C49-4E1F-96B9-E07CCBE61629Q38598987-9EF0F6C9-2F6C-410B-8F6B-832AAE5562B7Q38695031-2F00DBB0-3597-49BE-A65D-77EFCB18E57DQ39587966-8B854DB8-9E3A-4F48-950D-45881CBECD66Q40269181-847E39C0-2967-45F5-922D-53452A78ED4BQ46274946-A7260703-0061-499C-BE7D-F30340BFD006Q47848197-AD08CC8D-C892-4877-AE12-8544324411A7
P2860
The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The attenuation of central ang ...... per/zinc superoxide dismutase.
@ast
The attenuation of central ang ...... per/zinc superoxide dismutase.
@en
type
label
The attenuation of central ang ...... per/zinc superoxide dismutase.
@ast
The attenuation of central ang ...... per/zinc superoxide dismutase.
@en
prefLabel
The attenuation of central ang ...... per/zinc superoxide dismutase.
@ast
The attenuation of central ang ...... per/zinc superoxide dismutase.
@en
P2093
P2860
P1433
P1476
The attenuation of central ang ...... per/zinc superoxide dismutase.
@en
P2093
Alexander V Kabanov
Devika S Manickam
Elena V Batrakova
Erin G Rosenbaugh
Harold D Schultz
Irving H Zucker
James W Roat
Jing-Xiang Yin
Matthew C Zimmerman
P2860
P304
P356
10.1016/J.BIOMATERIALS.2010.03.026
P577
2010-04-07T00:00:00Z